鐛呯編闇蹭繚瑕栨嵎鐪艰棩姘
Land: Taiwan
Spr氓k: kinesisk
Kilde: 琛涚敓绂忓埄閮ㄩ鍝佽棩鐗╃鐞嗙讲 (Ministry of Health and Welfare, Food And Drug Administration)
Informasjon til brukeren
(PIL)
04-06-2021
Offentlig vurderingsrapport
(PAR)
12-06-2020
Send foresp酶rsel.
Aktiv ingrediens:
RETINOL PALMITATE;;PYRIDOXINE HYDROCHLORIDE;;CHLORPHENIRAMINE MALEATE;;NEOSTIGMINE METHYLSULFATE;;ASPARTATE POTASSIUM MAGNESIUM L- ( EQ TO MAGNESIUM POTASSIUM L-ASPARTATE);;D-ALPHA-TOCOPHEROL ACETATE;;TETRAHYDROZOLINE HCL
Tilgjengelig fra:
鐛呯帇瀹跺搧鑲′唤鏈夐檺鍏徃 鏂板寳甯備笁閲嶅崁閲嶆柊璺洓娈97铏18妯撲箣1 (24797652)
ATC-kode:
S01XA
Legemiddelform:
榛炵溂娑插姂
Sammensetning:
CHLORPHENIRAMINE MALEATE (0400000810) MG; NEOSTIGMINE METHYLSULFATE (1204000920) MG; ASPARTATE POTASSIUM MAGNESIUM L- ( EQ TO MAGNESIUM POTASSIUM L-ASPARTATE) (4020100452) MG; TETRAHYDROZOLINE HCL (5232000310) MG; RETINOL PALMITATE (8428001920) IU; PYRIDOXINE HYDROCHLORIDE (8810600330) MG; D-ALPHA-TOCOPHEROL ACETATE (8820000252) MG
Enheter i pakken:
濉戣啝鐡惰
Klasse:
瑁姐鍔
Resept typen:
閱斧钘ュ斧钘ュ姂鐢熸寚绀鸿棩鍝
Produsert av:
NITTO MEDIC CO., LTD. YATSUO PLANT 1-14-1 YASUUCHI, YATSUO-MACHI, TOYAMA-CITY, TOYAMA 939-2366, JAPAN JP
Terapeutisk omr氓de:
Other ophthalmologicals
Indikasjoner:
鏆檪绶╄В鍥犺紩寰溂閮ㄥ埡婵鎵寮曡捣涔嬩笉閬┿佹垨鐪肩潧绱咃紝鐪肩潧鐧紝鐪肩潧鐤插嫗銆
Produkt oppsummering:
鏈夋晥鏃ユ湡: 2027/03/07; 鑻辨枃鍝佸悕: SMILE 40EX EYE DROPS
Autorisasjon dato:
2012-03-07
